As of September 2024, Vcanbio Cell & Gene Engineering Corp. has a market cap of $1.24B. This makes Vcanbio Cell & Gene Engineering Corp. the world's 6876th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.04B | -22.20% |
2023 | $1.34B | 19.17% |
2022 | $1.12B | -32.61% |
2021 | $1.67B | 28.71% |
2020 | $1.29B | 15.83% |
2019 | $1.12B | 4.25% |
2018 | $1.07B | -42.82% |
2017 | $1.87B | 5.97% |
2016 | $1.77B | -58.78% |
2015 | $4.29B | 60.48% |
2014 | $2.67B | 69.07% |
2013 | $1.58B | 33.56% |
2012 | $1.18B | -21.28% |
2011 | $1.50B | 142.96% |
2010 | $618.87M | 24.57% |
2009 | $496.81M | 93.08% |
2008 | $257.31M | -50.57% |
2007 | $520.57M | 206.63% |
2006 | $169.77M | 49.66% |
2005 | $113.44M | -25.13% |
2004 | $151.51M | -70.25% |
2003 | $509.32M | -19.77% |
2002 | $634.80M | 11.61% |
2001 | $568.76M | 5.28% |
2000 | $540.25M | 98.66% |
1999 | $271.95M | 13.59% |
1998 | $239.41M | 16.55% |
1997 | $205.42M | 36.11% |
1996 | $150.91M | -4.00% |
1995 | $157.20M | -39.56% |
1994 | $260.09M | 57.64% |
1993 | $164.99M | - |